PREVENTION COULD BE LESS COST-EFFECTIVE THAN CURE: THE CASE OF HEPATITIS C SCREENING POLICIES IN FRANCE

Cost-Effectiveness in Health and Medicine

1996 • 6,853 citations

The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994

1999 • 3,083 citations

Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

1998 • 2,374 citations

Markov Models in Medical Decision Making

1993 • 2,353 citations

Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness

1995 • 1,342 citations

Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C

1998 • 1,318 citations

EASL International Consensus Conference on Hepatitis C Paris, 26–28 February 1999

1999 • 704 citations

INTERFERON ALFA-2b ALONE OR IN COMBINATION WITH RIBAVIRIN FOR THE TREATMENT OF RELAPSE OF CHRONIC HEPATITIS C

1998 • 363 citations

Estimates of the Cost-Effectiveness of a Single Course of Interferon-α2b in Patients with Histologically Mild Chronic Hepatitis C

1997 • 320 citations

Mortality in heroin addiction: impact of methadone treatment

1990 • 302 citations

Interferon for non-A, non-B chronic hepatitis

1991 • 294 citations

Death and survival in a cohort of heroin addicts from London clinics: a 22‐year follow‐up study

1994 • 274 citations

Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting

1999 • 257 citations

Sensitivity and specificity of third‐generation hepatitis C virus antibody detection assays: an analysis of the literature

2001 • 248 citations

Natural history of hepatitis C

1999 • 243 citations

Non-A, Non-B Post-Transfusion Hepatitis: Looking Back in the Second Decade

1993 • 239 citations

Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C.

1999 • 230 citations

The Decision Rules of Cost-Effectiveness Analysis

1996 • 205 citations

Pretreatment Evaluation of Chronic Hepatitis C

1998 • 196 citations

Hepatitis C in a French population-based survey, 1994: Seroprevalence, frequency of viremia, genotype distribution, and risk factors

1997 • 192 citations

Mortality of intravenous drug users in Rome: a cohort study.

1991 • 162 citations

Cost-Effectiveness of 6 and 12 Months of Interferon-α Therapy for Chronic Hepatitis C

1997 • 155 citations

Tentative guidelines for using clinical and economic evaluations revisited.

1993 • 111 citations

Mortality rates among opioid addicts in a longitudinal study.

1987 • 97 citations

Cost-effectiveness of 24 or 48 weeks of interferon alpha-2b alone or with ribavirin as initial treatment of chronic hepatitis c

2000 • 80 citations

Cost-effectiveness of 24 or 48 weeks of interferon α-2b alone or with ribavirin as initial treatment of chronic hepatitis c

2000 • 77 citations

Mortality of intravenous drug users living in Milan, Italy

1994 • 42 citations

mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: effects of interferon-alpha (IFN-α) treatment

1998 • 42 citations

Assessing the cost effectiveness of adjuvant therapies in early breast cancer using a decision analysis model

1993 • 39 citations

Assessment of a hepatitis C virus antibody assay in saliva for epidemiological studies

1998 • 35 citations

CLINICAL USE OF HEPATITIS C VIRUS TESTS FOR DIAGNOSIS AND MONITORING DURING THERAPY

1999 • 35 citations

Clinical evaluation of a single reaction, diagnostic polymerase chain reaction assay for the detection of hepatitis C virus RNA

1996 • 30 citations

Evaluation of newly developed microparticle enzyme immunoassays for the detection of HCV antibodies

2000 • 26 citations

Including polymerase chain reaction in screening for hepatitis C virus RNA in blood donations is not cost‐effective

2001 • 25 citations

Modeling therapeutic benefit in the midst of uncertainty

1996 • 20 citations

Evaluation of a new automated third-generation anti-HCV enzyme immunoassay

1996 • 17 citations

Principe de précaution et transfusion sanguine

2000 • 13 citations

Evaluation of clinical and laboratory aspects of antibody tests for detection of hepatitis C virus infection in blood donors and recipients from a low‐risk population

1994 • 11 citations

Duration of HCV infection as a predictor of nonresponse to interferon

1996 • 10 citations

Prevalence of HCV and HIV antibodies and related risk factors among entrants to the main southeastern French prison

1999 • 4 citations

Conférence de consensus Paris, 16-17 janvier 1997 Hépatite C dépistage et traitement

1997 • 2 citations

O11-9 Les receveurs de produits sanguins labiles en France métropolitaine. Étude Recept

1998 • 1 citations

Deleted Work

1955 • 0 citations